MacroGenics

MGNX · NASDAQ

$3.49+$0.16 (+4.80%)TodayMarket closed ·
Prev close $3.33

Who owns MGNX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 44.4% of MGNX’s shares.

  • Armistice Capital LLC7.9%
  • BlackRock Institutional Trust Company, N.A.6.6%
  • Vanguard Capital Management, LLC4.2%
  • Renaissance Technologies LLC4.1%
  • Next 6 largest institutions21.6%
  • All other shareholders55.6%
Top institutional holders of MGNX
HolderShares% of shares
Armistice Capital LLC5.01M7.88%
BlackRock Institutional Trust Company, N.A.4.22M6.64%
Vanguard Capital Management, LLC2.66M4.18%
Renaissance Technologies LLC2.63M4.14%
Acadian Asset Management LLC2.54M4.00%
Two Sigma Investments, LP2.48M3.90%
Bank of America Private Bank2.45M3.85%
Millennium Management LLC2.37M3.74%
Wasatch Global Investors Inc2.02M3.18%
RA Capital Management, LP1.86M2.93%

Largest mutual fund holders

Top mutual fund holders of MGNX
HolderShares% of shares
BB Biotech Fd9.92M15.61%
Vanguard Total Stock Market Index Fund1.93M3.03%
iShares Russell 2000 ETF1.55M2.45%
Wasatch Ultra Growth Fund1.12M1.76%
Wasatch Micro Cap Fund771.22K1.21%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $129.09K (1 trade) of MGNX on the open market, with no buys.

Latest MGNX insider transactions
InsiderTypeSharesValue
Bonvini EzioOption exercise8.00K$20.80K
Bonvini EzioOption exercise8.00K$20.80K
Peters Jeffrey StuartSale31.11K$129.09K
Bonvini EzioOption exercise40.00K$104.00K
Bonvini EzioOption exercise40.00K$104.00K
Ferrante Karen JeanAward22.00K—
Ferrante Karen JeanAward3.75K—
Koenig ScottAward22.00K—
Koenig ScottAward3.75K—
Jackson Scott ThomasAward22.00K—

Short interest

Settled Sep 30, 2026

Shares short
7.04M
Days to cover
10.90
% of shares outstanding
11.08%
Average daily volume
645.91K
Change since last report
+0.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.